Evidence map›Paper›PMID 40346057›Full record

ArticleNature communications2025

Molecular epidemiology of Ascaris lumbricoides following multiple rounds of community-wide treatment.

Toby Landeryou, Rosie Maddren, Jack Hearn, Mahlet Belachew, Santiago Rayment Gomez, Ewnetu Firdawek Liyew, Kathryn Forbes, Birhan Mengistu, Scott P Lawton, Jude Eze and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Predisposition to Ascaris lumbricoides reinfection in the Geshiyaro project in southern Ethiopia.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026
    Article
  2. Article
  3. Ultrastructural Evaluation (SEM) ofPathogens (Basel, Switzerland) · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Toby LanderyouCentre for Epidemiology and Planetary Health, School of Veterinary Medicine, Scotland's Rural College, Inverness, IV23JX, Scotland, UK. toby.landeryou@sruc.ac.uk.ORCID http://orcid.org/0000-0001-6025-1336
Rosie MaddrenDepartment of Infectious Disease Epidemiology, School of Public Health Building, Imperial College London, London, UK.
Jack HearnCentre for Epidemiology and Planetary Health, School of Veterinary Medicine, Scotland's Rural College, Inverness, IV23JX, Scotland, UK.ORCID http://orcid.org/0000-0003-3358-4949
Mahlet BelachewMalaria, Neglected Tropical Disease Research Team, Bacterial, Parasitic, Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.ORCID http://orcid.org/0000-0001-6263-4779
Santiago Rayment GomezDepartment of Infectious Disease Epidemiology, School of Public Health Building, Imperial College London, London, UK.
Ewnetu Firdawek LiyewMalaria, Neglected Tropical Disease Research Team, Bacterial, Parasitic, Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Kathryn ForbesDepartment of Infectious Disease Epidemiology, School of Public Health Building, Imperial College London, London, UK.
Birhan MengistuDepartment of Infectious Disease Epidemiology, School of Public Health Building, Imperial College London, London, UK.
Scott P LawtonCentre for Epidemiology and Planetary Health, School of Veterinary Medicine, Scotland's Rural College, Inverness, IV23JX, Scotland, UK.
Jude EzeCentre for Epidemiology and Planetary Health, School of Veterinary Medicine, Scotland's Rural College, Inverness, IV23JX, Scotland, UK.
Geremew TasewMalaria, Neglected Tropical Disease Research Team, Bacterial, Parasitic, Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Ufaysa AnguloMalaria, Neglected Tropical Disease Research Team, Bacterial, Parasitic, Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Roy AndersonDepartment of Infectious Disease Epidemiology, School of Public Health Building, Imperial College London, London, UK. roy.anderson@imperial.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Control and elimination of the parasite Ascaris lumbricoides relies on mass drug administration (MDA) using a limited number of anti-helminthics. Whilst these programs have reduced the infection intensity and prevalence within many endemic regions, patterns of transmission remain poorly understood. Reinfection commonly occurs following cessation of treatment due to the absence of acquired immunity post infection. Here, we utilise genomic data to understand parasite transmission within and between households in a community and the genomic impact of repeated MDA. We sequenced 54 whole-genomes from Ascaris worms obtained from individuals in a longitudinal cohort epidemiological study of transmission and drug treatment extending over 6 years. We found that fine-scale population structure exists in spatially distinct clusters of infected individuals with reinfection occurring within or between geographically close households. This observation helps inform the policy for future control in low prevalence settings suggesting more targeted treatment of infection hotspots. We found evidence of positive selection acting on members of gene families previously implicated in reduced drug efficacy but detected no impactful variants. As efforts to eliminate A. lumbricoides intensify, our study provides a foundation for genomic surveillance to help identify both who infects whom and the impact of repeated drug treatment.

Indexed as

AnthelminticsAscariasisAscaris lumbricoidesAdultAnimalsChildFemaleGenome, HelminthHumansLongitudinal StudiesMaleMass Drug AdministrationMolecular EpidemiologyReinfectionAnthelmintics

Identifiers

PMID40346057
PMCPMC12064652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.